- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Beyond the Rash: Collaborative Insights on Pediatric Atopic Dermatitis
RAD 2025: Lisa Swanson, MD, shares insights on pediatric atopic dermatitis, addressing questions from both a dermatologist's and an allergist's perspective.
At the 2025 Revolutionizing Atopic Dermatitis (RAD) conference in Nashville, TN, pediatric dermatologist Lisa Swanson, MD, joined allergist Anne Marie Singh, MD, for a collaborative presentation exploring clinical cross-talk between their specialties in the management of pediatric atopic dermatitis (AD). In this interview with Patient Care Online, Dr Swanson previews their unique Q&A-style session, which aims to dispel common misconceptions around food allergy as a driver of eczema and to highlight significant advances in nonsteroidal and systemic therapies. She also emphasizes the importance of multidisciplinary care and shared decision-making when counseling families. Watch the full video to learn what primary care physicians should keep top of mind when managing children with AD.
For more RAD 2025 meeting coverage, please click here.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
